Full text is available at the source.
Synergistic Copper‐Coordination/Glutathione Reduction Drives an In Situ Type II‐to‐Type I Photodynamic Switch in Iridium‐Based Photosensitizer Nanocomposites for Potentiated Cancer Immunotherapy
Copper and Glutathione Work Together to Change Iridium-Based Light-Activated Nanoparticles, Enhancing Cancer Immunotherapy
AI simplified
Abstract
Ir1@FA@MOFs demonstrate high tumor growth inhibition in 4T1 tumor-bearing mice.
- Tumor microenvironment-adaptive nanoparticles enable oxygen-independent photodynamic therapy (PDT).
- An engineered Ir(III) complex allows switching between oxygen-dependent and hypoxia-tolerant PDT modes.
- The nanoplatform depletes glutathione and generates reactive oxygen species under light irradiation.
- Mechanistic studies indicate that the nanoparticles induce various forms of cell death through mitochondrial damage.
- The treatment converts 'cold' tumors into immunogenic hotspots, enhancing immune response.
AI simplified